1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with proxicromil in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (proxicromil) | Trials (proxicromil) | Recent Studies (post-2010) (proxicromil) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 29 | 7 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coutts, S; Jones, H; Khandwala, A; Neiss, E; Pruss, T; Weinryb, I | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and proxicromil
| Article | Year |
|---|---|
REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
Topics: Animals; Antigens; Basophils; Calcimycin; Chromones; Cromolyn Sodium; Dextrans; Drug Synergism; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Lung; Mast Cells; Oxazoles; p-Methoxy-N-methylphenethylamine; Phosphatidylserines; Platelet Activating Factor; Rats; Tachyphylaxis; Time Factors | 1987 |